CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 985 of 1
Non-Antibody Products
Page 985 of 1,288
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| PLX4720 | An orally-available, highly selective inhibitor of B-RafV600E (IC50 = 13 n… | 1 mg | 15142-1 | More Info |
| PLX4720 | An orally-available, highly selective inhibitor of B-RafV600E (IC50 = 13 n… | 10 mg | 15142-10 | More Info |
| PLX4720 | An orally-available, highly selective inhibitor of B-RafV600E (IC50 = 13 n… | 25 mg | 15142-25 | More Info |
| PLX4720 | An orally-available, highly selective inhibitor of B-RafV600E (IC50 = 13 n… | 5 mg | 15142-5 | More Info |
| PLX51107 | A BET family protein inhibitor; binds to BD1 in BRD2, BRD3, BRD4, and BRDT… | 1 mg | 30742-1 | More Info |
| PLX51107 | A BET family protein inhibitor; binds to BD1 in BRD2, BRD3, BRD4, and BRDT… | 5 mg | 30742-5 | More Info |
| PLX51107 | A BET family protein inhibitor; binds to BD1 in BRD2, BRD3, BRD4, and BRDT… | 500 µg | 30742-500 | More Info |
| PLX5622 | A brain-penetrant CSF1R inhibitor (IC50 = 0.016 µM); selective for C… | 1 mg | 28927-1 | More Info |
| PLX5622 | A brain-penetrant CSF1R inhibitor (IC50 = 0.016 µM); selective for C… | 10 mg | 28927-10 | More Info |
| PLX5622 | A brain-penetrant CSF1R inhibitor (IC50 = 0.016 µM); selective for C… | 25 mg | 28927-25 | More Info |
| PLX5622 | A brain-penetrant CSF1R inhibitor (IC50 = 0.016 µM); selective for C… | 5 mg | 28927-5 | More Info |
| PLX647 | A dual inhibitor of FMS and KIT (IC50s = 28 and 16 nM, respectively); is s… | 10 mg | 18012-10 | More Info |
| PLX647 | A dual inhibitor of FMS and KIT (IC50s = 28 and 16 nM, respectively); is s… | 25 mg | 18012-25 | More Info |
| PLX647 | A dual inhibitor of FMS and KIT (IC50s = 28 and 16 nM, respectively); is s… | 5 mg | 18012-5 | More Info |
| PLX647 | A dual inhibitor of FMS and KIT (IC50s = 28 and 16 nM, respectively); is s… | 50 mg | 18012-50 | More Info |
| PLX7904 | A RAF inhibitor (IC50s = 2.4, 140, and 91 nM for mutant B-RAFV600E, wild-t… | 1 mg | 20710-1 | More Info |
| PLX7904 | A RAF inhibitor (IC50s = 2.4, 140, and 91 nM for mutant B-RAFV600E, wild-t… | 10 mg | 20710-10 | More Info |
| PLX7904 | A RAF inhibitor (IC50s = 2.4, 140, and 91 nM for mutant B-RAFV600E, wild-t… | 25 mg | 20710-25 | More Info |
| PLX7904 | A RAF inhibitor (IC50s = 2.4, 140, and 91 nM for mutant B-RAFV600E, wild-t… | 5 mg | 20710-5 | More Info |
| PLX5622 (hemifumarate) | A brain-penetrant CSF1R inhibitor (IC50 = 0.016 µM); selective for C… | 1 mg | 36277-1 | More Info |
| PLX5622 (hemifumarate) | A brain-penetrant CSF1R inhibitor (IC50 = 0.016 µM); selective for C… | 10 mg | 36277-10 | More Info |
| PLX5622 (hemifumarate) | A brain-penetrant CSF1R inhibitor (IC50 = 0.016 µM); selective for C… | 25 mg | 36277-25 | More Info |
| PLX5622 (hemifumarate) | A brain-penetrant CSF1R inhibitor (IC50 = 0.016 µM); selective for C… | 5 mg | 36277-5 | More Info |
| 2-PMAP | An inhibitor of APP production and Aβ secretion; reduces levels of AP… | 1 mg | 21021-1 | More Info |
| 2-PMAP | An inhibitor of APP production and Aβ secretion; reduces levels of AP… | 10 mg | 21021-10 | More Info |
| 2-PMAP | An inhibitor of APP production and Aβ secretion; reduces levels of AP… | 25 mg | 21021-25 | More Info |
| 2-PMAP | An inhibitor of APP production and Aβ secretion; reduces levels of AP… | 5 mg | 21021-5 | More Info |
| p38 MAPK Inhibitor | A potent inhibitor of p38 MAP kinase (IC50 = 35 nM) | 1 mg | 17650-1 | More Info |
| p38 MAPK Inhibitor | A potent inhibitor of p38 MAP kinase (IC50 = 35 nM) | 5 mg | 17650-5 | More Info |
| p38 MAPK Inhibitor | A potent inhibitor of p38 MAP kinase (IC50 = 35 nM) | 500 µg | 17650-500 | More Info |
| p38 MAPK Inhibitor IV | An ATP-competitive inhibitor of p38 MAPKs; inhibits p38α, p38β,… | 10 mg | 22219-10 | More Info |
| p38 MAPK Inhibitor IV | An ATP-competitive inhibitor of p38 MAPKs; inhibits p38α, p38β,… | 25 mg | 22219-25 | More Info |
| p38 MAPK Inhibitor IV | An ATP-competitive inhibitor of p38 MAPKs; inhibits p38α, p38β,… | 5 mg | 22219-5 | More Info |
| p38 MAPK Inhibitor VIII | An inhibitor of p38α (IC50 = 39 nM) and p38β MAP kinases with 8… | 1 mg | 21229-1 | More Info |
| p38 MAPK Inhibitor VIII | An inhibitor of p38α (IC50 = 39 nM) and p38β MAP kinases with 8… | 10 mg | 21229-10 | More Info |
| p38 MAPK Inhibitor VIII | An inhibitor of p38α (IC50 = 39 nM) and p38β MAP kinases with 8… | 5 mg | 21229-5 | More Info |
| 7-(p-Methoxybenzylamino)-4-nitrobenz-2,1,3-oxadiazole | A fluorescent probe for hydrophobic regions of proteins; upon binding to a… | 100 mg | 39668-100 | More Info |
| 7-(p-Methoxybenzylamino)-4-nitrobenz-2,1,3-oxadiazole | A fluorescent probe for hydrophobic regions of proteins; upon binding to a… | 25 mg | 39668-25 | More Info |
| 7-(p-Methoxybenzylamino)-4-nitrobenz-2,1,3-oxadiazole | A fluorescent probe for hydrophobic regions of proteins; upon binding to a… | 250 mg | 39668-250 | More Info |
| 7-(p-Methoxybenzylamino)-4-nitrobenz-2,1,3-oxadiazole | A fluorescent probe for hydrophobic regions of proteins; upon binding to a… | 50 mg | 39668-50 | More Info |
| p-methyl-N-salicyloyl Tryptamine | A neuroprotective agent; reduces LPS-induced NO production in C6 cells and… | 10 mg | 38958-10 | More Info |
| p-methyl-N-salicyloyl Tryptamine | A neuroprotective agent; reduces LPS-induced NO production in C6 cells and… | 25 mg | 38958-25 | More Info |
| p-methyl-N-salicyloyl Tryptamine | A neuroprotective agent; reduces LPS-induced NO production in C6 cells and… | 5 mg | 38958-5 | More Info |
| 1P-MiPLA (solution) | An analytical reference standard categorized as a lysergamide; intended fo… | 100 µg | 38498-100 | More Info |
| PMK ethyl glycidate | A precursor in the synthesis of methylenedioxy phenethylamines and ampheta… | 1 mg | 21990-1 | More Info |
| PMK ethyl glycidate | A precursor in the synthesis of methylenedioxy phenethylamines and ampheta… | 5 mg | 21990-5 | More Info |
| PMK Glycidic Acid (sodium salt) | An analytical reference standard categorized as a precursor in the synthes… | 1 mg | 19685-1 | More Info |
| PMK Glycidic Acid (sodium salt) | An analytical reference standard categorized as a precursor in the synthes… | 5 mg | 19685-5 | More Info |
| PMK methyl glycidate | A precursor in the synthesis of methylenedioxy phenethylamines and ampheta… | 10 mg | 21833-10 | More Info |
| PMK methyl glycidate | A precursor in the synthesis of methylenedioxy phenethylamines and ampheta… | 5 mg | 21833-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile